NCT01507181View on ClinicalTrials.gov

Ketamine For Suicidal Ideation

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Suicidal Ideation
Interventions
DRUG

Ketamine

single dose IV ketamine, .5mg/kg infused over 40 minutes

DRUG

Midazolam

single dose IV midazolam, .45mg/kg infused over 40 minutes

Trial Locations (1)

10027

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

James Murrough

OTHER

NCT01507181 - Ketamine For Suicidal Ideation | Biotech Hunter | Biotech Hunter